enow.com Web Search

  1. Ads

    related to: car t cells

Search results

  1. Results from the WOW.Com Content Network
  2. CAR T cell - Wikipedia

    en.wikipedia.org/wiki/CAR_T_cell

    CAR T cells destroy cells through several mechanisms, including extensive stimulated cell proliferation, increasing the degree to which they are toxic to other living cells (cytotoxicity), and by causing the increased secretion of factors that can affect other cells such as cytokines, interleukins and growth factors.

  3. Engineered CAR T cell delivery - Wikipedia

    en.wikipedia.org/wiki/Engineered_CAR_T_cell_delivery

    Engineered chimeric antigen receptor (CAR)-T cell delivery is the methodology by which clinicians introduce the cancer-targeting therapeutic system of the CAR-T cell to the human body. CAR-T cells, which utilizes genetic modification of human T-cells to contain antigen binding sequences in addition to the receptor systems CD4 or CD8 , are ...

  4. Cellular adoptive immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cellular_adoptive...

    Chimeric antigen receptor T-cells (CAR-T) are predominantly used in cancer immunotherapy. T-cells are harvested from patients' bodies and infused after genetic engineering (equipped with CAR construct). And the currently developing mRNA vaccine technology may provide the possibility for in vivo CAR induction in the future

  5. Cancer immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Cancer_immunotherapy

    Multifunctional alginate scaffolds for T cell engineering and release (MASTER) is a technique for in situ engineering, replication and release of genetically engineered T cells. It is an evolution of CAR T cell therapy. T cells are extracted from the patient and mixed with a genetically engineered virus that contains a cancer-targeting gene (as ...

  6. Gene therapy for blood diseases - Wikipedia

    en.wikipedia.org/wiki/Gene_therapy_for_blood...

    The genetically modified T-cells are administered back to the patients as a treatment. Leukemia is a group of blood cancers commonly found in children younger than 15 and elders older than 55. [3] In 2017, tisagenlecleucel (Kymriah™), [2] the first CAR-T cell therapy approved by the FDA, became available to anyone up to the age of 25 with ...

  7. Tisagenlecleucel - Wikipedia

    en.wikipedia.org/wiki/Tisagenlecleucel

    The T cells are engineered to target a protein called CD19 that is common on B cells. A chimeric T cell receptor ("CAR-T") is expressed on the surface of the T cell. [medical citation needed] The platform invented at the University of Pennsylvania was clinically developed by Novartis, including market authorization, and real world evidence.

  1. Ads

    related to: car t cells